Literature DB >> 22791390

Lethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia induction.

Laura E Lunde1, Charles Chuang, Michael A Linden, Sarah A Williams, Zohar Sachs, Zuzan Cayci, Jo-Anne H Young, Celalettin Ustun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22791390      PMCID： PMC4339090          DOI： 10.1002/ajh.23290

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  22 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

3.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

Authors:  Drosos E Karageorgopoulos; Evridiki K Vouloumanou; Fotinie Ntziora; Argyris Michalopoulos; Petros I Rafailidis; Matthew E Falagas
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

Review 4.  Current approaches to diagnosis and treatment of invasive aspergillosis.

Authors:  Brahm H Segal; Thomas J Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

5.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Authors:  J Maertens; O Marchetti; R Herbrecht; O A Cornely; U Flückiger; P Frêre; B Gachot; W J Heinz; C Lass-Flörl; P Ribaud; A Thiebaut; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2010-07-26       Impact factor: 5.483

Review 6.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo-Coco
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

7.  Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings.

Authors:  B C Ashdown; R D Tien; G J Felsberg
Journal:  AJR Am J Roentgenol       Date:  1994-01       Impact factor: 3.959

8.  Changes in causes of death over time after treatment for invasive aspergillosis.

Authors:  John R Wingard; Patricia Ribaud; Haran T Schlamm; Raoul Herbrecht
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

Review 9.  Retinoic acid syndrome: a review.

Authors:  E Patatanian; D F Thompson
Journal:  J Clin Pharm Ther       Date:  2008-08       Impact factor: 2.512

10.  Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

Authors:  David W Denning; Kieren A Marr; Wendi M Lau; David P Facklam; Voravit Ratanatharathorn; Cornelia Becker; Andrew J Ullmann; Nita L Seibel; Patricia M Flynn; Jo-Anne H van Burik; Donald N Buell; Thomas F Patterson
Journal:  J Infect       Date:  2006-05-06       Impact factor: 6.072
View more
  1 in total

Review 1.  Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature.

Authors:  Gregorio Di Franco; Enrico Tagliaferri; Erica Pieroni; Edoardo Benedetti; Simone Guadagni; Matteo Palmeri; Niccolò Furbetta; Daniela Campani; Giulio Di Candio; Mario Petrini; Franco Mosca; Luca Morelli
Journal:  Infection       Date:  2018-01-22       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.